Source comparison
Summary Comparison Table
Primary mechanism Gene expression remodelling, Cu metalloprotein delivery, Nrf2 activation VEGFR2-eNOS angiogenesis, FAK-paxillin cytoskeletal repair, NF-κB suppression Collagen biology Strong — COL1A1/COL3A1 upregulation, lysyl oxidase, decorin; dermal focus
This comparison does not assign a generated winner or score.
- Primary mechanism
- Gene expression remodelling, Cu metalloprotein delivery, Nrf2 activation
- VEGFR2-eNOS angiogenesis, FAK-paxillin cytoskeletal repair, NF-κB suppression
- Collagen biology
- Strong — COL1A1/COL3A1 upregulation, lysyl oxidase, decorin; dermal focus
- Moderate — EGR1-driven; tendon/connective tissue focus
- Angiogenesis
- Moderate — VEGF upregulation, Cu-HIF
- Strong — VEGFR2-eNOS, documented in multiple models
- Antioxidant
- Strong — SOD1/CAT/GPX1 transcriptomic signature, Cu delivery
- Moderate — Nrf2-HO-1 contextual activation
- Senescence (SASP)
- Strong — SASP suppression, SA-β-gal reduction
- Not characterised in senescence models
- Skin/wound healing
- Primary strength — extensive dermatological literature
- Documented, less skin-specific than GHK-Cu
- Neuroprotection
- Emerging — BDNF/NGF upregulation, Aβ-Cu interaction
- Strong — validated across ischaemia, TBI, SCI, PD models
- GI biology
- Limited data
- Primary strength — ulcer, IBD, motility, gut-brain axis
- Oral bioavailability
- Limited (Cu complex oral stability uncertain)
- Active orally and parenterally in rodent models
- Best for research
- Skin ageing, antioxidant biology, SASP, collagen transcriptomics
- Angiogenesis, multi-tissue repair, GI, CNS, systemic protection
- All comparisons are based on preclinical research data. Both compounds are Research Use Only with no human therapeutic claims implied.
- 🇬🇧 UK Research Peptides: PeptidesLab UK supplies COA-verified GHK-Cu and BPC-157 for research and laboratory use. View UK stock →
- William is a research analyst at Peptides Lab UK, specialising in research peptides, laboratory compounds, and sourcing standards for high-purity peptide products.